Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10771628rdf:typepubmed:Citationlld:pubmed
pubmed-article:10771628lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:10771628lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:10771628lifeskim:mentionsumls-concept:C0457454lld:lifeskim
pubmed-article:10771628lifeskim:mentionsumls-concept:C1444662lld:lifeskim
pubmed-article:10771628pubmed:issue2lld:pubmed
pubmed-article:10771628pubmed:dateCreated2000-5-4lld:pubmed
pubmed-article:10771628pubmed:abstractTextTreatment guidelines for depression have typically focused on diagnosis, how to initiate antidepressants, and duration of therapy, while very little is discussed about discontinuing treatment. With the advent of the serotonin-specific reuptake inhibitors (SSRIs), there is now growing evidence to support a "discontinuation syndrome" associated with withdrawal of therapy. This article describes two cases and presents a review of the literature.lld:pubmed
pubmed-article:10771628pubmed:languageenglld:pubmed
pubmed-article:10771628pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10771628pubmed:citationSubsetIMlld:pubmed
pubmed-article:10771628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10771628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10771628pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10771628pubmed:statusMEDLINElld:pubmed
pubmed-article:10771628pubmed:issn0043-3284lld:pubmed
pubmed-article:10771628pubmed:authorpubmed-author:NussSSlld:pubmed
pubmed-article:10771628pubmed:authorpubmed-author:KincaidC RCRlld:pubmed
pubmed-article:10771628pubmed:issnTypePrintlld:pubmed
pubmed-article:10771628pubmed:volume96lld:pubmed
pubmed-article:10771628pubmed:ownerNLMlld:pubmed
pubmed-article:10771628pubmed:authorsCompleteYlld:pubmed
pubmed-article:10771628pubmed:pagination405-7lld:pubmed
pubmed-article:10771628pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:meshHeadingpubmed-meshheading:10771628...lld:pubmed
pubmed-article:10771628pubmed:articleTitleSerotonin discontinuation syndrome: does it really exist?lld:pubmed
pubmed-article:10771628pubmed:affiliationDept. of Medicine, Robert C. Byrd Health Sciences Center of West Virginia University, Morgantown, USA.lld:pubmed
pubmed-article:10771628pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10771628pubmed:publicationTypeCase Reportslld:pubmed